Stryker price target raised to $440 from $425 at Bernstein

Bernstein raised the firm’s price target on Stryker (SYK) to $440 from $425 and keeps an Outperform rating on the shares. The firm notes the company reported a strong Q4, as revenue of $6.44B grew 10.2% organic and beat consensus by 1.2%. Bernstein also highlights the bullish outlook as Stryker expects continued strength in underlying markets driven by growth of robotic-assisted surgery, favorable demographics, and healthy levels of patient activity.